FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056112 [Registered on: 04/08/2023] Trial Registered Prospectively
Last Modified On: 10/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   DURVA TAILA IN URETHRAL STRICTURE 
Scientific Title of Study
Modification(s)  
EFFICACY OF DURVA TAILA UTTARBASTI IN THE MANAGEMENT OF STRICURE URETHRA AN OPEN LABELLED CLINICAL STUDY 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR IMRANNABI JABBARALI NADAF 
Designation  PG SCHOLAR 
Affiliation  PARUL INSTITUTE OF AYURVED 
Address  PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760

Vadodara
GUJARAT
391760
India 
Phone  9834381686  
Fax    
Email  imran.nadaf78@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR HEMANT TOSHIKHANE 
Designation  PROFESSOR  
Affiliation  PARUL INSTITUTE OF AYURVED 
Address  PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760

Vadodara
GUJARAT
391760
India 
Phone  8469496525  
Fax    
Email  Drhemantt@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR HEMANT TOSHIKHANE 
Designation  PROFESSOR  
Affiliation  PARUL INSTITUTE OF AYURVED 
Address  PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760

Vadodara
GUJARAT
391760
India 
Phone  8469496525  
Fax    
Email  Drhemantt@gmail.com  
 
Source of Monetary or Material Support  
PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760 
 
Primary Sponsor  
Name  DR IMRANNABI JABBARALI NADAF 
Address  PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR IMRANNABI JABBARALI NADAF  PARUL AYURVED HOSPITAL  PARUL INSTITUTE OF AYURVED OPD NO 106 DEPARTMENT OF SHALYATANTRA LIMDA VADODARA 391760
Vadodara
GUJARAT 
9834381686

imran.nadaf78@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PARUL INSTITUTE OF AYURVED  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N359||Urethral stricture, unspecified. Ayurveda Condition: MUTRA-VEGARODHAH/MUTRAGRAHA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-uttara-bastiH, उत्तर-बस्तिः (Procedure Reference: SAHASRA YOGA TAILA VARGA, Procedure details: UTTARBASTI WITH DURVA TAILA DAILY ONCE A TIME)
(1) Medicine Name: DURVA, Reference: SAHASRA YOGA TAILA VARGA, Route: Urethral, Dosage Form: Taila, Dose: 40(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Diagnosed cases of Stricture Urethra will be included
Patients of either gender of age 25 TO 75years with history of stricture urethra of mild to moderate symptoms will be selected for the study
 
 
ExclusionCriteria 
Details  Age group below 25 years and above 75 years
Patients of impacted calculus in the urethra and bladder Neck
Benign Prostatic Hyperplasia
Uncontrolled Diabetes Mellitus
Nephritic Syndrome and Neoplasm of lower urinary tract
Congenital and severely symptomatic Stricture Urethra
HIV and HbsAg positive
Carcinoma patients
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
WILL REDUCE THE SYMPTOMS OF URETHRAL STRICTURE EG DRIBBLING MICTURITION URINE STREAM WITHIN 7 DAYS WITH UTTARBASTI   7 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
IMPROVE THE QUALITY OF LIFE AND REDUCE SYMPTOMS OF URETHRAL STRICTURE  7 DAYS 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  15/08/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM

•To compare clinical efficacy of Durva tailauttarbastiin the management of urethral stricture.

OBJECTIVES

•      To PrepareDurva Taila.

•      To study the effect of DurvaTailaUttarbasti in improving the subjective symptoms of urethral stricture.

•      Analysis of Durva Taila in wound healing by HPTLC method.

To attain the probable mode of action of effect of Durva Taila in Urethral stricture 
Close